1. Association between aspirin‐induced hemoglobin decline and outcome after acute ischemic stroke in G6PD‐deficient patients
- Author
-
Zhijian Liang, Jian Yu, Shihui Xing, Jinsheng Zeng, Weisheng Deng, Jianle Li, Fubing Ouyang, Yicong Chen, Yusheng Zhang, Weixian Huang, and Zilin Ou
- Subjects
Lung Diseases ,Male ,medicine.medical_specialty ,Endpoint Determination ,Anemia ,Bilirubin ,Glucosephosphate Dehydrogenase ,Gastroenterology ,Cohort Studies ,Hemoglobins ,chemistry.chemical_compound ,Modified Rankin Scale ,G6PD deficiency ,Physiology (medical) ,Internal medicine ,medicine ,Humans ,Pharmacology (medical) ,Prospective Studies ,Stroke ,Aged ,Ischemic Stroke ,Pharmacology ,Aspirin ,business.industry ,Anti-Inflammatory Agents, Non-Steroidal ,Original Articles ,hemoglobin ,Middle Aged ,medicine.disease ,stroke ,Confidence interval ,Psychiatry and Mental health ,Glucosephosphate Dehydrogenase Deficiency ,Treatment Outcome ,chemistry ,outcome ,Original Article ,Female ,Hemoglobin ,business ,Cohort study ,medicine.drug - Abstract
Aims The risk of hemoglobin decline induced by low‐dose aspirin in glucose‐6‐phosphate dehydrogenase (G6PD) deficiency remains unknown, and its influence on stroke outcome remains to be investigated. This study aimed to evaluate the effect of G6PD deficiency on hemoglobin level during aspirin treatment and its association with outcome after acute ischemic stroke. Methods In total, 279 patients (40 G6PD‐deficient and 239 G6PD‐normal) with acute ischemic stroke treated with aspirin 100 mg/day from a cohort study were examined. The primary safety endpoint was a hemoglobin decline ≥25 g/L or 25% from baseline within 14 days after aspirin treatment. Poor outcomes were defined as a modified Rankin Scale score ≥2 at 3 months. The χ 2 test was used to compare stroke outcomes, and multivariate logistic regression analyses were performed to analyze the association between hemoglobin level and outcomes. Results The G6PD‐deficient group had lower baseline hemoglobin and tended to develop comorbid pulmonary infection more frequently (p, Hemoglobin decrease with bilirubin increase after aspirin treatment in patients with G6PD deficiency suggests hemolysis, which may influence stroke prognosis. The risk of hemoglobin decline should be carefully monitored in G6PD‐deficient stroke patients taking aspirin.
- Published
- 2021
- Full Text
- View/download PDF